查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451706

2024-2032 年按產品、技術（聚合酶鍊式反應、微陣列、定序等）、應用、最終用戶和地區分類的 DNA 甲基化市場報告

DNA Methylation Market Report by Product, Technology (Polymerase Chain Reaction, Microarray, Sequencing, and Others), Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2023年全球DNA甲基化市場規模達14億美元。展望未來， IMARC Group預計到2032年市場規模將達到45億美元，2024-2032年複合年成長率（CAGR）為13.5%。由於表觀遺傳學研究技術的不斷進步、甲基化生物標記識別在疾病診斷中重要性的不斷提升以及精準醫療產品應用的大幅成長，該市場正在經歷穩定成長。

DNA甲基化市場分析：

市場成長與規模：在表觀遺傳學研究在了解疾病機制、推進精準醫療和確定潛在治療標靶方面越來越多的採用的推動下，全球市場正在經歷強勁成長。隨著研究人員和產業認知到 DNA 甲基化分析的關鍵作用，市場規模正在擴大，涵蓋診斷、製藥和學術研究等不同領域的應用。

主要市場促進因素：主要促進因素包括對個人化醫療的需求不斷成長、用於疾病診斷的 DNA 甲基化生物標記的識別以及藥物發現中表觀遺傳學見解的整合。此外，慢性病的盛行率不斷上升以及對先進診斷工具的需求也促進了市場的成長。

技術進步：高通量定序技術、微陣列平台和資料分析軟體的不斷進步，提高了DNA甲基化分析的效率和準確性。這些進步使研究人員能夠探索複雜的表觀遺傳景觀，有助於更深入地了解 DNA 甲基化模式及其對健康和疾病的影響。

產業應用：該產品廣泛應用於各個產業，包括臨床診斷、製藥和生物技術研究以及學術研究。 DNA 甲基化分析是疾病檢測、生物標記發現和藥物開發的重要工具，促進其融入醫療保健、生命科學和生物醫學研究的各個方面。

主要市場趨勢：主要趨勢包括定序技術的主導地位、基因治療創新應用的出現以及對精準醫療的日益重視。市場正在見證向全面的全基因組分析的轉變，使研究人員能夠解開複雜的表觀遺傳機制並確定新的治療標靶。

地理趨勢：從地理上看，在先進的醫療基礎設施、大量的研究投資和對基因組研究的關注的推動下，北美引領市場。在不斷增加的醫療保健舉措和不斷提高的個人化醫療意識的推動下，亞太地區正在見證顯著的成長。歐洲仍然是重要的參與者，利用完善的研究基礎設施和合作來推動 DNA 甲基化分析的進步。

競爭格局：競爭格局的特點是主要參與者在研發方面投入大量資金。公司正專注於開發創新技術、擴大產品組合併形成策略合作以保持競爭優勢。該市場既有老牌企業，也有新興企業，為不斷變化的格局做出了貢獻。

挑戰與機會：挑戰包括分析大規模表觀基因組資料的複雜性、標準化方案的需求以及使用表觀遺傳資訊的倫理考量。然而，這些挑戰為技術進步、標準化工作和道德準則的發展提供了機會，這可以進一步推動市場的成長。

未來展望：市場前景廣闊，預計將持續成長。技術的不斷進步、精準醫學應用的增加以及表觀遺傳景觀的不斷探索預計將推動市場向前發展。我們將透過協作努力應對挑戰，促進創新並擴大 DNA 甲基化分析跨不同產業整合的機會。

DNA 甲基化市場趨勢：

表觀遺傳學研究進展

由於表觀遺傳學研究的不斷進步，市場正在經歷顯著成長。研究人員和生物技術專家擴大闡明複雜的調控機制及其在各種生物過程中的影響，包括基因表現、細胞分化和疾病發展。新一代定序和高通量甲基化檢測等尖端技術的可用性有助於在全基因組範圍內對這些甲基化模式進行全面分析。隨著我們對表觀基因組的了解不斷擴大，對先進甲基化分析工具和服務的需求不斷增加，推動了市場的成長。

甲基化生物標記鑑定在疾病診斷中的重要性不斷提高

DNA甲基化在基因表現調控中發揮著至關重要的作用，並與包括癌症在內的各種疾病的發生和進展密切相關。這些甲基化生物標記的鑑定已在疾病診斷、預後和治療決策中發揮重要作用。人們越來越認知到這些甲基化特徵是疾病狀態的有價值的指標，從而推動了市場的發展。研究人員和臨床醫生正在利用這種甲基化分析來發現新的生物標記物，用於早期檢測、監測治療反應和開發個人化治療干預措施，從而促進市場的擴張。

精準醫療領域的應用不斷成長

採用根據患者獨特的遺傳和表觀遺傳特徵為個別患者量身定做的精準醫療方法是市場的關鍵驅動力。 DNA 甲基化模式作為重要的表觀遺傳標記，影響疾病易感性、治療反應和患者結果。隨著精準醫學在醫療保健領域的重要性日益凸顯，甲基化分析成為表徵患者特異性表觀基因組變異不可或缺的一部分。此應用超出了腫瘤學範圍，擴展到各種疾病，包括神經退化性疾病和心血管疾病。人們日益認知到個人化治療策略可以顯著改善患者的治療效果，這刺激了對甲基化分析的需求，從而將市場定位在精準醫學不斷變化的領域的前沿。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球 DNA 甲基化市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 耗材
    • 市場走向
    • 市場預測
  • 試劑盒和試劑
    • 市場走向
    • 市場預測
  • 酵素
    • 市場走向
    • 市場預測
  • 儀器和軟體
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依技術

  • 聚合酶鍊式反應 (PCR)
    • 市場走向
    • 市場預測
  • 微陣列
    • 市場走向
    • 市場預測
  • 定序
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按應用

  • 基因治療
    • 市場走向
    • 市場預測
  • 臨床研究
    • 市場走向
    • 市場預測
  • 診斷
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院和診斷實驗室
    • 市場走向
    • 市場預測
  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 研究與學術界
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abcam plc.
    • Active Motif Inc.
    • Diagenode SA (Hologic Inc.)
    • EpiGentek Group Inc.
    • Illumina Inc.
    • Merck KGaA
    • New England Biolabs Inc.
    • PerkinElmer Inc.
    • Qiagen NV
    • Thermo-Fisher Scientific Inc.
    • Zymo Research Corporation
Product Code: SR112024A6890

The global DNA methylation market size reached US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.5% during 2024-2032. The market is experiencing steady growth driven by the continual technological advancements in epigenetic research, the rising significance of methylation biomarker identification in disease diagnosis, and the considerable growth in product applications in precision medicine.

DNA Methylation Market Analysis:

Market Growth and Size: The global market is experiencing robust growth, driven by the increasing adoption of epigenetic research in understanding disease mechanisms, advancing precision medicine, and identifying potential therapeutic targets. As researchers and industries recognize the pivotal role of DNA methylation analysis, the market is expanding in size, encompassing applications across diverse sectors such as diagnostics, pharmaceuticals, and academic research.

Major Market Drivers: Key drivers include the rising demand for personalized medicine, the identification of DNA methylation biomarkers for disease diagnosis, and the integration of epigenetic insights in drug discovery. Additionally, the increasing prevalence of chronic diseases and the need for advanced diagnostic tools contribute to the market growth.

Technological Advancements: Continuous progress in high-throughput sequencing technologies, microarray platforms, and data analysis software enhances the efficiency and accuracy of DNA methylation analysis. These advancements enable researchers to explore the intricate epigenetic landscape, contributing to a deeper understanding of DNA methylation patterns and their implications in health and disease.

Industry Applications: The product finds extensive applications in various industries, including clinical diagnostics, pharmaceutical and biotechnology research, and academic studies. DNA methylation analysis serves as a valuable tool for disease detection, biomarker discovery, and drug development, fostering its integration into diverse facets of healthcare, life sciences, and biomedical research.

Key Market Trends: Key trends include the dominance of sequencing technologies, the emergence of innovative applications in gene therapy, and the growing emphasis on precision medicine. The market is witnessing a shift towards comprehensive genome-wide analysis, enabling researchers to unravel complex epigenetic mechanisms and identify novel therapeutic targets.

Geographical Trends: Geographically, North America leads the market, driven by advanced healthcare infrastructure, significant research investments, and a focus on genomic research. The Asia-Pacific region is witnessing notable growth, propelled by increasing healthcare initiatives and a rising awareness of personalized medicine. Europe remains a significant player, leveraging well-established research infrastructure and collaborations for advancements in DNA methylation analysis.

Competitive Landscape: The competitive landscape is characterized by key players investing heavily in research and development. Companies are focusing on developing innovative technologies, expanding their product portfolios, and forming strategic collaborations to maintain a competitive edge. The market showcases a mix of established players and emerging entrants, contributing to a changing landscape.

Challenges and Opportunities: Challenges include the complexity of analyzing large-scale epigenomic data, the need for standardized protocols, and ethical considerations in the use of epigenetic information. However, these challenges present opportunities for technological advancements, standardization efforts, and the development of ethical guidelines, which can further propel the market's growth.

Future Outlook: The future of the market appears promising, with sustained growth anticipated. Ongoing advancements in technology, increasing applications in precision medicine, and the continuous exploration of epigenetic landscapes are expected to drive the market forward. Challenges will be addressed through collaborative efforts, fostering innovation and expanding opportunities for the integration of DNA methylation analysis across diverse industries.

DNA Methylation Market Trends:

Advancements in epigenetic research

The market is experiencing significant growth due to continuous advancements in epigenetic research. Researchers and biotechnologists are increasingly unraveling the complex regulatory mechanisms and its implications in various biological processes, including gene expression, cellular differentiation, and disease development. The availability of cutting-edge technologies, such as next-generation sequencing and high-throughput methylation assays, facilitates comprehensive analysis of these methylation patterns at a genome-wide scale. As our understanding of the epigenome expands, the demand for advanced methylation analysis tools and services rises, driving the growth of the market.

Rising significance of methylation biomarker identification in disease diagnosis

DNA methylation plays a crucial role in the regulation of gene expression and is intricately involved in the development and progression of various diseases, including cancer. The identification of these methylation biomarkers has become instrumental in disease diagnosis, prognosis, and therapeutic decision-making. The market is propelled by the increasing recognition of these methylation signatures as valuable indicators of disease states. Researchers and clinicians are leveraging this methylation analysis to discover novel biomarkers for early detection, monitoring treatment responses, and developing personalized therapeutic interventions, thereby fostering the market's expansion.

Growing applications in precision medicine

The adoption of precision medicine approaches, tailored to individual patients based on their unique genetic and epigenetic profiles, is a key driver for the market. DNA methylation patterns serve as essential epigenetic markers that influence disease susceptibility, treatment responses, and patient outcomes. As precision medicine gains prominence in healthcare, methylation analysis becomes integral for characterizing patient-specific epigenomic variations. This application extends beyond oncology to various diseases, including neurodegenerative disorders and cardiovascular conditions. The growing realization that personalized therapeutic strategies can significantly improve patient outcomes fuels the demand for this methylation profiling, positioning the market at the forefront of the changing landscape in precision medicine.

DNA Methylation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, technology, application, and end user.

Breakup by Product:

Consumables

Kits and Reagents

Enzymes

Instrument and Software

Consumables account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables, kits and reagents, enzymes, and instrument and software. According to the report, consumables represented the largest segment.

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Microarray

Sequencing

Others

Sequencing holds the largest share of the industry

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes polymerase chain reaction (PCR), microarray, sequencing, and others. According to the report, sequencing accounted for the largest market share.

Breakup by Application:

Gene Therapy

Clinical Research

Diagnostics

Others

Clinical research represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes gene therapy, clinical research, diagnostics, and others. According to the report, clinical research represented the largest segment.

Breakup by End User:

Hospital and Diagnostic Laboratories

Pharmaceutical and Biotechnology Companies

Research and Academia

Pharmaceutical and biotechnology companies represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospital and diagnostic laboratories, pharmaceutical and biotechnology companies, and research and academia. According to the report, pharmaceutical and biotechnology companies represented the largest segment.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest DNA methylation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abcam plc.

Active Motif Inc.

Diagenode S.A. (Hologic Inc.)

EpiGentek Group Inc.

Illumina Inc.

Merck KGaA

New England Biolabs Inc.

PerkinElmer Inc.

Qiagen N.V.

Thermo-Fisher Scientific Inc.

Zymo Research Corporation

Key Questions Answered in This Report:

  • How has the global DNA methylation market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global DNA methylation market?
  • What is the impact of each driver, restraint, and opportunity on the global DNA methylation market?
  • What are the key regional markets?
  • Which countries represent the most attractive DNA methylation market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the DNA methylation market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the DNA methylation market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the DNA methylation market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the DNA methylation market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global DNA methylation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global DNA Methylation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Kits and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Enzymes
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Instrument and Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microarray
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Gene Therapy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinical Research
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital and Diagnostic Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Pharmaceutical and Biotechnology Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research and Academia
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abcam plc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Active Motif Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Diagenode S.A. (Hologic Inc.)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 EpiGentek Group Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Illumina Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Merck KGaA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 New England Biolabs Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 PerkinElmer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Qiagen N.V.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Thermo-Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Zymo Research Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: DNA Methylation Market: Major Drivers and Challenges
  • Figure 2: Global: DNA Methylation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: DNA Methylation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: DNA Methylation Market: Breakup by Product (in %), 2023
  • Figure 5: Global: DNA Methylation Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: DNA Methylation Market: Breakup by Application (in %), 2023
  • Figure 7: Global: DNA Methylation Market: Breakup by End User (in %), 2023
  • Figure 8: Global: DNA Methylation Market: Breakup by Region (in %), 2023
  • Figure 9: Global: DNA Methylation (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: DNA Methylation (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: DNA Methylation (Kits and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: DNA Methylation (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: DNA Methylation (Enzymes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: DNA Methylation (Enzymes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: DNA Methylation (Instrument and Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: DNA Methylation (Instrument and Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: DNA Methylation (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: DNA Methylation (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: DNA Methylation (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: DNA Methylation (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: DNA Methylation (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: DNA Methylation (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: DNA Methylation (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: DNA Methylation (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: DNA Methylation (Gene Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: DNA Methylation (Gene Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: DNA Methylation (Clinical Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: DNA Methylation (Clinical Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: DNA Methylation (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: DNA Methylation (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: DNA Methylation (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: DNA Methylation (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: DNA Methylation (Hospital and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: DNA Methylation (Hospital and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: DNA Methylation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: DNA Methylation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: DNA Methylation (Research and Academia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: DNA Methylation (Research and Academia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: DNA Methylation Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: DNA Methylation Industry: Drivers, Restraints, and Opportunities
  • Figure 89: Global: DNA Methylation Industry: Value Chain Analysis
  • Figure 90: Global: DNA Methylation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: DNA Methylation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: DNA Methylation Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: DNA Methylation Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: DNA Methylation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: DNA Methylation Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: DNA Methylation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: DNA Methylation Market: Competitive Structure
  • Table 8: Global: DNA Methylation Market: Key Players